Cardiovascular-kidney-metabolic health: a presidential advisory from the American Heart Association

Cited by (1,000)

Items 401–500 of 1,000

1. Animal Models for Studying Developmental Origins of Cardiovascular–Kidney–Metabolic Syndrome
   You‐Lin Tain, Ying-Jui Lin, Chien‐Ning Hsu · 2025 · Biomedicines
2. Hydroxytyrosol as a Mitochondrial Homeostasis Regulator: Implications in Metabolic Syndrome and Related Diseases
   Jie Xu, Huanglong Wei, Zhenyu Sun, Wei Li, Jiangang Long, Jiankang Liu, Zhihui Feng, Ke Cao · 2025 · Antioxidants
3. Early Childhood Food Insecurity and Cardiovascular Health in Young Adulthood
   Emily Lam, Abigail Gauen, Namratha R. Kandula, Daniel A. Notterman, Noreen Goldman, Donald M. Lloyd‐Jones, Norrina B. Allen, Nilay S. Shah · 2025 · JAMA Cardiology
4. Climate Vulnerability and Cardiovascular‐Kidney‐Metabolic Disease in the United States
   Pedro Rafael Vieira de Oliveira Salerno, Peter Lewis, Zhuo Chen, Jean-Eudes Dazard, Sarju Ganatra, Eman Nayaz Ahmed, Khurram Nasir, Salil Vasudeo Deo, Sanjay Rajagopalan, Sadeer G Al-Kindi · 2025 · Journal of the American Heart Association
5. Animal models for preclinical research on multifactorial human conditions: The case of cardiovascular-kidney-metabolic syndrome
   Magdalena Jasińska-Stroschein · 2025 · Biomedicine & Pharmacotherapy
6. Metabolic disorder–associated kidney disease and diabetic kidney disease in developing countries
   Sunita Bavanandan, Irene L. Noronha, Irma Tchokhonelidze, Adrian Liew · 2025 · Kidney International
7. Associations of cardiovascular-kidney-metabolic conditions with all-cause and cardiovascular mortality among US adults: a population-based cohort study
   Songfeng Zhao, Hongyi Liu, Aihua Liu · 2025 · BMC Cardiovascular Disorders
8. Risk Factor Control in U.S. Adults With Cardiovascular-Kidney-Metabolic Multimorbidity, 1999-2020
   John W. Ostrominski, Jamie S. Hirsch, Benjamin Miao, Brendan J. Clark, Bonnie M.K. Donato, Jonathan J. Woolley, Christina M. Parrinello, Thomas O’Connell, Muthiah Vaduganathan · 2025 · Journal of the American College of Cardiology
9. Cardiovascular outcomes and safety of semaglutide in non-overweight populations with type 2 diabetes: a comparison with dipeptidyl peptidase 4 inhibitors
   Takefumi Kishimori, Takao Kato, Atsuyuki Wada, Akira Tani, Ryosuke Yamaji, Jumpei Koike, Yoshihiro Iwasaki, Takehiro Matsumoto, Takafumi Yagi, Masaharu Okada · 2025 · European Heart Journal - Quality of Care and Clinical Outcomes
10. The health stage of cardiovascular-kidney-metabolic (CKM) syndrome is useful for predicting all-cause mortality in patients with type 2 diabetes: a cohort study in a period prior to the standard use of recent pharmacotherapy
    Keitaro Nishizawa, Marenao Tanaka, Tatsuya Sato, Tomohito Gohda, Nozomu Kamei, Maki Murakoshi, Yukinori Akiyama, Wataru Kawaharata, Hiroki Aida, Hidemichi Kouzu et al. · 2025 · Journal of Diabetes and its Complications
11. Implementation Barriers to Evidence-Based Cardiovascular-Kidney-Metabolic Syndrome Management
    Gina Davis, Dana Kim, Min Jun, Sradha S. Kotwal · 2025 · Heart Lung and Circulation
12. Social determinants of health and progression to cardio–renal–metabolic multimorbidity and mortality in people with prediabetes: A prospective cohort study
    Rong Hua, Aimin Yang, Le Gao, Elaine Chow, Wenjing Ji, Yin Ting Cheung · 2025 · Diabetes Obesity and Metabolism
13. The Impact of Cardiovascular-Kidney-Metabolic Syndrome Staging on Depression Risk: A National Study
    Bowen Zha, Angshu Cai, Hongrui Yu, Zhexue Wang · 2025 · Heart Lung and Circulation
14. Decline in glomerular filtration rate as an endpoint in heart failure clinical trials: challenges and solutions
    Lesley A. Inker, Brendon Lange Neuen, Wendy I. McCallum, Muthiah Vaduganathan, Tom Greene, Hiddo J.L. Heerspink · 2025 · European Heart Journal
15. Osteoarthritis as a clinical marker of cardiovascular-kidney-metabolic multimorbidity: a population-based cohort study in China
    Yue Li Zou, Yanyan Zhang, Xiujiang Sun, Wenbo Zhao, Guodong Zhang · 2025 · Frontiers in Endocrinology
16. Shared mechanistic pathways of glucagon signalling: Unlocking its potential for treating obesity, metabolic dysfunction‐associated steatotic liver disease, and other cardio‐kidney‐metabolic conditions
    Guy W. Neff · 2025 · Diabetes Obesity and Metabolism
17. Association between cardiovascular-kidney-metabolic syndrome, inflammatory biomarkers, and cardiovascular outcomes: Insights from the MESA study
    Muhammad Imtiaz Ahmad, Parag Anilkumar Chevli, Saeid Mirzai, Jared Alexander Spitz, Garima V. Sharma, João A.C. Lima, Khurram Nasir, Michael Joseph Blaha, Neha Jadeja Pagidipati, Roger Scott Blumenthal et al. · 2025 · Atherosclerosis
18. Cardio-kidney-metabolic complexity in patients with atrial fibrillation: an analysis from the prospective GLORIA-AF registry phase III
    Giulio Francesco Romiti, Davide Antonio Mei, Bernadette Corica, Marco Proietti, Giuseppe Boriani, Brian Olshansky, Tze‐Fan Chao, Menno V. Huisman, Gregory Y.H. Lip, the GLORIA-AF Investigators · 2025 · Cardiovascular Diabetology
19. Cardiovascular-kidney-metabolic progression associated with major adverse liver outcomes: mediating roles of plasma metabolites
    Jingjing Liang, Yongqi Liang, Liwen Chen, Mengyi Cai, Shuxian Li, Lu He, Yining Xu, Yilan Tan, Linna Li, Xianbo Wu et al. · 2025 · Frontiers in Nutrition
20. Long-term clinical outcome and risk stratification across stages of cardiovascular-kidney-metabolic syndrome in a nationwide cohort
    Hyunjin Kim, Byung Sik Kim, Hasung Kim, Jungkuk Lee, Ha Hye Jo, Dong Wook Kim, Jeong‐Hun Shin, Ki‐Chul Sung · 2025 · The Korean Journal of Internal Medicine
21. Association of the triglyceride-glucose index with cardiovascular outcomes across cardiovascular-kidney-metabolic syndrome stages
    Byung Sik Kim, Hyun‐Jin Kim, Shinje Moon, Hasung Kim, Jungkuk Lee, Jeong‐Hun Shin · 2025 · The Korean Journal of Internal Medicine
22. Association of cardiovascular-kidney-metabolic syndrome with depression and all-cause mortality: a population-based observational study
    Wei Liu, Zhijuan Li, Pu Ma · 2025 · Frontiers in Nutrition
23. Which insulin resistance indices best predict future frailty progression in a cardiovascular-kidney-metabolic syndrome stage 0–3 population: a national prospective cohort and machine learning study
    Ruikang Liu, Guangyi Yang, Yiying Liu, Jun Li, Botan Xu, Guancheng Ye, Xuanchun Huang, Shiyi Tao, Tiantian Xue, Yonghao Li et al. · 2025 · Diabetology & Metabolic Syndrome
24. Clinical utility of an AI-based retinal imaging model for cardiovascular risk prediction in hypertensive retinopathy
    Dongjin Nam, Yong-Hwan Jang, Yong-Seok Lee, Jaewon Seo, Sahil Thakur, Simon Nusinovici, Moonsu Kim, Yong Un Shin, Hwan-Cheol Park, Sunjin Hwang · 2025 · Canadian Journal of Ophthalmology
25. Weight-adjusted waist index outperforms other obesity indices for cardiovascular disease prediction in cardiovascular-kidney-metabolic syndrome: insights from UK biobank
    Tianyu Wang, Lixiao Zhang, Pengfei Chen, Chen Chen, Lin Xu, Ming Guo · 2025 · BMC Public Health
26. Night shift work and its interaction with sleep duration and chronotype, and risk of cardiovascular–kidney–metabolic diseases in the UK Biobank
    Dat Thien Tran, Susanne Strohmaier, Magdalena Żebrowska, Tianyi Huang, Kyriaki Papantoniou, Susan S Redline, Richa Saxena, Martin K. Rutter, Eva S. Schernhammer · 2025 · European Journal of Preventive Cardiology
27. Chronic kidney disease burden from 1990 to 2023 in China: national and provincial insights from the Global Burden of Diseases study 2023
    Guanhao He, Jiangmei Liu, Yi Lin, Jinlei Qi, Jianxiong Hu, Peng Yin, Tao Liu, Ziqiang Lin, Fengrui Jing, Jinling You et al. · 2025 · The Lancet Regional Health - Western Pacific
28. Repurposing GLP-1 receptor agonists for alcohol use disorder: a systematic review and meta-analysis
    Amir Nasrollahizadeh, Ghazaleh Kheiri, Sepide Javankiani, Sadra Kheiri, Seyedeh Fatemeh Hamzavi, Mehdi Karimi, Ehsan Amini‐Salehi, Mohammad Amin Karimi · 2026 · Diabetology & Metabolic Syndrome
29. Cardiovascular-Kidney-Metabolic Medication Eligibility Across National Survey, Community-Based, and Ambulatory Healthcare Samples
    Louisa A. Mounsey, Mandana Chitsazan, Ivy Shi, Pedro H. Ribeiro, Juhi K. Parekh, Athar Roshandelpoor, Chiadi E. Ndumele, Norrina B. Allen, Sadiya S. Khan, Bruce M. Psaty et al. · 2026 · JAMA Cardiology
30. Cardiovascular–Kidney–Metabolic Syndrome Stages, Echocardiographic Characteristics, and Heart Failure Risk: The Atherosclerosis Risk in Communities Study
    Mats Christian Højbjerg Lassen, John W. Ostrominski, Brian Lee Claggett, Chiadi E. Ndumele, Tor Biering‐Sørensen, Kunihiro Matsushita, Elizabeth Selvin, Josef Coresh, Amil M. Shah, Scott David Solomon et al. · 2026 · Circulation
31. Association Between Young Adult Characteristics and Blood Pressure Trajectories
    Jaejin An, Heidi J. Fischer, Liang Ni, Mengying Xia, Soon Kyu Choi, Kerresa L. Morrissette, Rong X. Wei, Kristi Reynolds, Paul Muntner, Monika M. Safford et al. · 2024 · Journal of the American Heart Association
32. Enhancing clinical service design for multimorbidity management: A comprehensive approach to joined‐up care for diabetes, chronic kidney disease, and heart failure
    Saif Al‐Chalabi, Smeeta Sinha, Philip A. Kalra · 2024 · Diabetic Medicine
33. Advancements in Incident Heart Failure Risk Prediction and Screening Tools
    Daniel S. Matasic, Ralph Zeitoun, Gregg C. Fonarow, Alexander C. Razavi, Roger Scott Blumenthal, Martha Gulati · 2024 · The American Journal of Cardiology
34. Sex-differences in reporting of statin-associated diabetes mellitus to the US Food and Drug Administration
    David Peter Kao, James L Martin, Christina L. Aquilante, Elise L. Shalowitz, Katarina R. Leyba, Elizabeth L. Kudron, Jane E.B. Reusch, Judith G. Regensteiner · 2024 · BMJ Open Diabetes Research & Care
35. Waist to hip ratio modifies the cardiovascular risk of lipoprotein (a): Insights from MESA
    Muhammad Imtiaz Ahmad, Parag Anilkumar Chevli, Saeid Mirzai, Rishi Raj Rikhi, Harpeet Bhatia, Neha Jadeja Pagidipati, Roger Scott Blumenthal, Alexander C. Razavi, Kathleen R. Ruddiman, Jared Alexander Spitz et al. · 2025 · Progress in Cardiovascular Diseases
36. Cardiometabolic disease management: influences from epigenetics
    Natalia Atzemian, S A Mohammed, Ludovica Di Venanzio, Era Gorica, Sarah Costantino, Frank Thomas Ruschitzka, Francesco Paneni · 2025 · Epigenomics
37. The American Heart Association at 100: A Century of Scientific Progress and the Future of Cardiovascular Science: A Presidential Advisory From the American Heart Association
    Mitchell S.V. Elkind, Donna K. Arnett, Ivor J. Benjamin, Robert H. Eckel, Augustus O. Grant, Steven R. Houser, Alice K. Jacobs, Daniel W. Jones, Rose Marie Robertson, Ralph L. Sacco et al. · 2024 · Circulation
38. High Prevalence of the Cardiovascular-Kidney-Metabolic Syndrome Among US Adults From 1999-2020 - An analysis of the NHANES survey
    Zhejia Tian, Samira Soltani, Johann K Bauersachs, Kai Martin Schmidt-Ott, Anette Melk, Bernhard M. W. Schmidt · 2024 · medRxiv
39. Adipokines and Vascular Modulators in CKM: Emerging Biomarkers as Diagnostic and Therapeutic Targets
    Cezara-Andreea Gerdanovics, S. Suciu, Olga Hilda Orasan, Ioana Para, Vladiana Turi, Mircea Vasile Milaciu, Mirela-Georgiana Perné, Lorena Ciumărnean, Nicoleta Valentina Leach, Teodora Alexescu et al. · 2025 · International Journal of Molecular Sciences
40. Routine measurement of cardiometabolic disease risk factors in primary care in England before, during, and after the COVID-19 pandemic: A population-based cohort study
    Frederick Ka Wing Ho, Caroline E Dale, Mehrdad A. Mizani, Thomas Bolton, Ewan R. Pearson, Jonathan Valabhji, Christian Delles, Paul I. Welsh, Shinya Nakada, Daniel Mackay et al. · 2024 · PLoS Medicine
41. Approaches to raise awareness of CKD among patients and the general population
    Delphine S. Tuot, Laura Plantinga · 2025 · Nature Reviews Nephrology
42. Heart Failure—Focus on Kidney Replacement Therapy: Why, When, and How?
    Ewa Wojtaszek, Marlena Kwiatkowska, Małgorzata Sobieszczańska‐Małek, Tomasz Głogowski, Aleksandra Kaszyńska, Michał Markowski, Sławomir Jerzy Małyszko, Jolanta Małyszko · 2025 · International Journal of Molecular Sciences
43. RNA Therapies in Cardio-Kidney-Metabolic Syndrome: Advancing Disease Management
    Abbas Mohammadi, Azin Karimian, Kasra Shokri, Ashkan Mohammadi, Nazanin Hazhir Karzar, Rayeheh Bahar, Azar Radfar, Mohammadreza Pakyari, Behnam N. Tehrani · 2025 · Journal of Cardiovascular Translational Research
44. Estimating Glucose Disposal Rate and Its Association with All-Cause and Etiologically Specific Mortality in Cardiovascular-Kidney-Metabolic Syndrome among US Adults: Insights from NHANES 1999–2018
    Xiaohan Ma, Sheng Chen, Jiang He · 2025 · Cardiorenal Medicine
45. Association of cardiovascular-kidney-metabolic overlap with physical function and prognosis in older patients with heart failure: a post hoc analysis of the FRAGILE-HF and SONIC-HF
    Taisuke Nakade, Yuya Matsue, Yoshiaki Ikeda, Daichi Maeda, Nobuyuki Kagiyama, Yudai Fujimoto, Hanako Inoue, Tsutomu Sunayama, Taishi Dotare, Kentaro Jujo et al. · 2025 · European Journal of Preventive Cardiology
46. Trends in use of sodium-glucose cotransporter 2 inhibitors among people with type 2 diabetes following hospitalisation with heart failure: A population-based study
    Jialing Lin, Tamara Y. Milder, Claire T. Deakin, Juliana de Oliveira Costa, Alys Havard, Brendon Lange Neuen, Nicholas Allan Buckley, David B. Brieger, Jerry Richard Greenfield, Min Jun et al. · 2025 · Diabetes Research and Clinical Practice
47. Prediction of depression risk in middle-aged and elderly Cardiovascular-Kidney-Metabolic syndrome patients by social and environmental determinants of health: an interpretable machine learning approach using longitudinal data from China
    Xinyi Xu, Xinru Li, Xiyan Li, Benli Xue, Xiao Zheng, Shujuan Xiao, Lingli Yang, Xinyi Zhang, Chengyu Chen, Ting Zheng et al. · 2025 · Journal of Health Population and Nutrition
48. The combined impact of chronic kidney disease and ulcer severity on incident cardiovascular events in patients with diabetes‐related foot ulceration
    Nick S.R. Lan, Jonathan Hiew, Ivana Ferreira, Jens Carsten Ritter, Laurens A. Manning, P. Gerry Fegan, Emma Jane Hamilton, Girish Dwivedi · 2025 · Physiological Reports
49. The role of triglyceride-glucose index in the progression of cardiovascular-kidney-metabolic syndrome: findings from the China health and retirement longitudinal study
    Xingyu Zhou, Yisi Liu, Jiafei Peng, Xianliang Zhou, Hongtao Wei · 2025 · Frontiers in Cardiovascular Medicine
50. Association between urinary heavy metals and cardiovascular-kidney-metabolic syndrome: mediating roles of TyG, WWI, and eGFR
    Jian-Ping Liu, Yuanying Song, Rong Luo, Sufang Wang, Pinglei Pan, Lijian Han · 2025 · Frontiers in Nutrition
51. Family history of non-communicable diseases and the risk of cardiovascular-kidney-metabolic syndrome
    Hyeseung Lee, Jinyoung Jeong, Yesol Yim, Lee Smith, Damiano Pizzol, Jiyoung Hwang, Dong Keon Yon · 2025 · Scientific Reports
52. Association between the cardiometabolic index and cardiovascular disease risk in patients with cardiovascular-kidney-metabolic syndrome: a cohort study
    De-Gang Mo, Tao Liu, Jingming Bai, Min Liu, Qian-Feng Han, Heng-Chen Yao · 2025 · BMC Cardiovascular Disorders
53. The association between life's essential 8 health behavior component score and all-cause and cardiovascular mortality among U.S. adults with cardiovascular-kidney-metabolic syndrome stages 0–3
    Yifei Wang, Tianshan Dong, Bin Wang, Ping Zhang · 2025 · Preventive Medicine
54. Identifying clusters of people with Multiple Long-Term Conditions using Large Language Models: a population-based study
    Alexander Smith, Thomas E Beaney, Carinna Hockham, Bowen Su, Paul Elliott, Laura Emily Downey, Spiros Denaxas, Payam Mamaani Barnaghi, Abbas Dehghan, Ioanna Tzoulaki · 2025 · npj Digital Medicine
55. Predicting Risk of Cardiovascular Disease EVENTs (PREVENT) Equations: What Clinicians Need to Know?
    Abdul Jabbar, Ali Bin, Inam, Maha, Butt, Nausharwan, Khan, Sadiya S., Sheikh, Sana, Khoja, Adeel, Perry, Benjamin, Gomez, Gerardo Zavala, Slipczuk, Leandro, Virani, Salim S. · 2025 · Current Atherosclerosis Reports
56. Sarcopenia and cardiovascular disease among adults with cardiovascular-kidney-metabolic syndrome stages 0-3: A prospective cohort study
    Yupeng Wei, Xiaopeng Hu · 2025 · American Journal of Preventive Cardiology
57. Cadmium exposure and advanced cardiovascular-kidney-metabolic syndrome: An integrated multi-organ perspective based on epidemiology and adverse outcome pathways
    Yuchong He, Xianghong Jasmine Zhou, Weichao Huang, Yuwei Wu, Zilong Zhang, Yuming Jin, Fei Li, Guo Chen, Kai Xiong Tao, Yu Zhan et al. · 2025 · Ecotoxicology and Environmental Safety
58. Association of Frailty Status with Staging and Mortality Risk of Cardiovascular-Kidney-Metabolic Syndrome in Middle-Aged and Older Populations: Insights from the 1999–2018 National Health and Nutrition Examination Survey
    Zhenkun Yang, Shuang Wu, Yuan-Jie Li, Hongyu Liu, Manlin Zhao, Yang Xu, Yun-Yu Chen, Yang Chen, Gregory Y.H. Lip · 2025 · Journal of Clinical Medicine
59. Non-conventional lipid parameters predict the risk of rapid kidney function decline in patients with cardiovascular-kidney-metabolic syndrome: The first cohort study evidence from CHARLS
    Mengying Dong, Xueqi Chen, Jian‐Gen Liu, Chunjian Li · 2025 · Experimental Gerontology
60. Association of estimated glucose disposal rate with all-cause and cardiovascular mortality in individuals with cardiovascular-kidney-metabolic syndrome: Two prospective cohorts
    Yupeng Wei, Jiangtao Li · 2025 · American Journal of Preventive Cardiology
61. Finerenone: Evidence for Benefit in Early Stages of Cardiovascular-Kidney-Metabolic Syndrome
    Diego Francisco Márquez, Alberto Ortíz, Daniel González‐Moreno, Luis Miguel Ruilope, Gema Ruiz‐Hurtado · 2025 · Cardiorenal Medicine
62. Sarcopenia (defined by low muscle mass) as a predictor of disease progression and mortality in cardiovascular-kidney-metabolic syndrome
    Diar Zooravar · 2025 · Diabetology & Metabolic Syndrome
63. Correlation between overall lifestyle score and advanced stages among patients with cardiovascular–kidney–metabolic syndrome: NHANES 2011–2020
    Ping Li, Xiaoqing Sun, Yangfei Sun, Hongxue Shang, Dingyuan Tu · 2025 · European journal of medical research
64. Endothelial dysfunction and cardiovascular outcomes in pre-menopausal women with high vs low breast fat accumulation: The role of TSP-1
    Celestino Sardu, Giovanni Francesco Nicoletti, Maria Consiglia Trotta, Gorizio Pieretti, Gianluca Gatta, Roberto Grella, Nunzia D’ Onofrio, Maria Luisa Balestrieri, Daniele La Forgia, Ludovica Vittoria Marfella et al. · 2025 · American Journal of Preventive Cardiology
65. Association of metal and metalloid exposure with cardiovascular-kidney-metabolic syndrome: mediation by inflammation, oxidative stress, and aging
    Shuai Zhang, Hanhan Tang, Linqing Pan, Minglian Zhou · 2025 · BMC Public Health
66. Evaluation, Management and Therapeutic Approach of Cardiovascular–Kidney–Metabolic Syndrome: A Multidisciplinary Delphi Expert Consensus
    Domingo Orozco‐Beltrán, Borja Quiroga, Alberto Esteban‐Fernández, Ana Lorenzo Almorós, Virginia Bellido, Teresa Benedito Pérez de Inestrosa, Rubén de Haro, Xoana Taboada, Juan Carlos Romero-Vigara · 2025 · Journal of Clinical Medicine
67. Next-Generation SGLT2 Inhibitors: Innovations and Clinical Perspectives
    Dana Emilia Man, Daniel Marius Duda-Seiman, Simona Ruxanda Dragan · 2025 · Biomedicines
68. Associations between the CHG index, its modified versions and incident stroke in patients with early-stage CKM syndrome: a nationwide cohort study
    Ke Li, Ying Li, Sili Jiang, Wenli Xing, Lei Zhao · 2026 · European journal of medical research
69. Causal demonstration of adiposity-induced adipose-specific signaling derangements in the pathogenesis of the clinical features of the cardiovascular-kidney metabolic syndrome
    Milton Packer · 2026 · Cardiovascular Diabetology
70. Modern Management of CKM Syndrome: Use of GLP-1 Receptor Agonists in a Multidisciplinary Setting—Expert Group Recommendations from Kuwait
    Waleed A. Al-Dahi, Abdullah Alenezi, Thamer Alessa, Rashed Alhamdan, Khaldoon Al-Humood, Ahmed Alqallaf, Torki M AlOtaibi, Heba AlRajab, Abdulmuhsen M. Alshammari, Anas Alyousef et al. · 2026 · Diabetes Therapy
71. Association between triglyceride-glucose index and related indicators with heart failure–related mortality in individuals with early-stage cardiovascular-kidney-metabolic syndrome
    Xiandu Jin, Yurong Feng, Chang Liu, Tianwei Cheng, Yanye Jin, Zibin Shao, Yongyu Bian, Hao Wu, Jiao Li, Yue Liu et al. · 2026 · Cardiovascular Diabetology
72. Assessing the contribution of plastic-associated obesogenic compounds to cardiometabolic diseases
    Jacob Warger, Michaela Lucas, Andrew Lucas · 2023 · Current Opinion in Endocrinology Diabetes and Obesity
73. The Cardiac-Kidney-Liver (CKL) syndrome: the “real entity” of type 2 diabetes mellitus
    Niki Katsiki, Genovefa D. Kolovou, Andreas J. Melidonis, Maciej Banach · 2024 · Archives of Medical Science
74. Cardio-reno-Metabolic health: discussing the recommendations of the American Heart Association
    M. Ya. Izmaylova, Tatiana Yu. Demidova, Валентович Валерия Владимировна · 2024 · FOCUS Endocrinology
75. Paving a Path to Equity in Cardiorenal Care
    Dinushika Mohottige · 2024 · Seminars in Nephrology
76. High-dimensional iterative causal forest (hdiCF) for subgroup identification using health care claims data
    Tiansheng Wang, Virginia Pate, Richard Wyss, John B. Buse, Michael R. Kosorok, Til Stürmer‎ · 2024 · American Journal of Epidemiology
77. Efficacy of a culturally tailored mobile health lifestyle intervention on cardiovascular health among African Americans with preexisting risk factors: The FAITH! Trial
    Mathias Lalika, Sarah M. Jenkins, Sharonne N. Hayes, Clarence Jones, Lora E. Burke, Lisa A. Cooper, Christi A. Patten, LaPrincess C. Brewer · 2024 · Digital Health
78. Cardiovascular Disease Risk Estimates in the US CKD Population Using the PREVENT Equation
    Carl Peter Walther, L. Parker Gregg, Sankar Dass Navaneethan · 2025 · American Journal of Kidney Diseases
79. Preclinical modeling of metabolic syndrome to study the pleiotropic effects of novel antidiabetic therapy independent of obesity
    Jonathan Paul Mochel, Jessica L. Ward, Thomas Blondel, Debosmita Kundu, Maria M. Merodio, Claudine Zemirline, Emilie Guillot, Ryland T. Giebelhaus, A. Paulina de la Mata, Chelsea A. Iennarella‐Servantez et al. · 2024 · Scientific Reports
80. Ignoring Mental Well-Being Is Costing Lives
    Roger Scott Blumenthal, Adhya Mehta, Rishi Chandiramani · 2024 · JACC Advances
81. 2025 ACC/AHA Clinical Practice Guidelines Core Principles and Development Process
    Otto, Catherine M., Abdullah, Abdul R., Davis, Leslie L., Ferrari, Victor A., Fremes, Stephen, Mukherjee, Debabrata, Prestera, Lauren, Ziaeian, Boback · 2026 · JACC
82. Spatiotemporal landscape of kidney in a mouse model of hyperuricemia at single‐cell level
    Haining Chang, Qianru Tao, Lan Wei, Yangyang Wang, Chao Tu · 2025 · The FASEB Journal
83. New insights into atherosclerotic cardiovascular disease through the lens of metabolism: expanding our approach
    Junbo Ge · 2025 · Cardiology Plus
84. On the front lines of cardiovascular-kidney-metabolic syndrome: Review of GLP-1 and Dual GLP-1/GIP receptor agonists in CV and kidney health
    Lavinia Salama, Levi Sinn · 2025 · American Journal of Health-System Pharmacy
85. Chronic kidney disease prevalence and outcomes in patients with type 2 diabetes or prediabetes at high cardiovascular risk: results from the CINEMA program
    Sanjana Datla, Zainab Albar, Elke Eaton, Jodie Porges, Matthew Nennstiel, Claire Sullivan, Lloyd A. Greene, Sadeer G Al-Kindi, Elizabeth Anne Montgomery, Aparna Padiyar et al. · 2025 · American Journal of Preventive Cardiology
86. Adherence to a Healthy Plant-Based Diet and Cardiovascular-Kidney-Metabolic Risk Factors in Patients with Moderate to Advanced Chronic Kidney Disease
    Shang-Li Hung, Ting‐Yun Lin, Szu‐Chun Hung · 2025 · Journal of the American Nutrition Association
87. Association between hemoglobin glycation index and the risk of cardiovascular disease in early-stage cardiovascular-kidney-metabolic syndrome: evidence from the China health and retirement longitudinal study
    Huiyi Liu, Shuai Mao, Yunzhang Zhao, Lisha Dong, Yifan Wang, Chao Lv, Tong Yin · 2025 · Frontiers in Endocrinology
88. Hyperkalemia risk of finerenone versus spironolactone in CKD patients with type 2 diabetes
    Abiodun Benjamin Idowu, Kevin Bryan Lo, Olayinka Adebolu, Michael Hamilton, Peter Abdelmaseeh, Sankar Dass Navaneethan, Janani Rangaswami · 2025 · Nephrology Dialysis Transplantation
89. Sodium-glucose transporter 2 inhibitors and cardiovascular-kidney-metabolic syndrome: a narrative review
    Yuqing Wang, Yaqing Wang, Xiaojie He, Xiaodong Li · 2025 · Frontiers in Endocrinology
90. Cardiovascular-kidney-metabolic overlaps, clinical outcomes, and quality of life in patients with acute heart failure
    Jingkuo Li, Lubi Lei, Lihua Zhang, Yuan‐Lin Guo, Xin Yuan · 2025 · The journal of nutrition health & aging
91. Association between DASH diet and metabolic syndrome in US adults: a cross-sectional study
    Jianing Liu, Rui Yang, Pei Ma, Xiaobo Zhu · 2025 · Frontiers in Public Health
92. Total-body positron emission tomography: Investigating mechanisms in cardiovascular-kidney-metabolic syndrome
    Jenifer Michelle Brown, Daniel M. Huck · 2025 · Journal of Nuclear Cardiology
93. A primary care guide to the screening and pharmacologic management of chronic kidney disease in people living with type 2 diabetes
    Eugene E. Wright, Ana María Cebrián Cuenca, Daniel Ngui · 2025 · Primary care diabetes
94. Association between dietary index for gut microbiota and cardiovascular-kidney-metabolic syndrome: a population-based study
    Dan Long, Chenhan Mao, Haoyu An, Ying Zhu, Yin Xu · 2025 · Frontiers in Nutrition
95. Associations between Life’s Crucial 9 and severity, all-cause mortality, and cardiovascular mortality in individuals with cardiovascular-kidney-metabolic syndrome: the mediating role of phenotypic age acceleration
    Jingkuo Li, Zengxin Xu, Jiayi Lin, Shunxiang Luo, Shanghua Xu · 2025 · Frontiers in Nutrition
96. Metabolic syndrome–associated kidney disease in young adolescents and children
    Rupesh Raina, Jieji Hu, Eugene Yu-hin Chan, Jared Hinton, Mark M. Mitsnefes · 2025 · Kidney International
97. Intrinsic capacity and its change predict cardiovascular disease risk in early cardiovascular-kidney-metabolic syndrome: a nationwide cohort study
    Fei Song, Mengjin Hu, Jinggang Xia, Chunlin Yin · 2025 · Open Heart
98. Cardiovascular-kidney-metabolic syndrome: A new frontier or simple rebranding?
    Jennifer Manne‐Goehler, François Venter, Mohammed Kumail Ali, Juan Víctor Ariel Franco · 2025 · PLoS Medicine
99. Randomised controlled trial of a low plastic diet and lifestyle intervention for adults with cardiometabolic risk factors: the Plastic Exposure Reduction Transforms Health (PERTH) trial – a protocol
    Andrew R. Lucas, Amelia J. Harray, Lelinh Duong, S. Herrmann, Philip Vlaskovsky, Michelle Trevenen, Dick C. Chan, Hannah Papendorf, Tony Smith, Lilith Flint et al. · 2025 · BMJ Open
100. Prematurity, Neonatal Complications, and the Development of Childhood Hypertension
     Kartikeya Makker, Jordan R. Kuiper, Tammy McLoughlin Brady, Xiumei Hong, Guoying Wang, Colleen Pearson, Keia Sanderson, Thomas Michael O’Shea, Xiaobin Wang, Khyzer B. Aziz · 2025 · JAMA Network Open